Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B

Updated on: March 30,2024 0

Researchers unveil the origin of second pediatric cancers and chemotherapy-induced mutations in healthy tissues

byInstitute for Research in Biomedicine (IRB Barcelona)The origin of second solid tumors of cases 3 (A–D) and 4 (E–F). A, Eight years after the development of NB, the child presented with MRT. B

Updated on:March 30,2024 0

Chemo toxicity: A common gene test could save hundreds of lives each year

by Arthur Allen, KFF Health NewsCredit: Unsplash/CC0 Public DomainOne January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died

Updated on: March 30,2024 0

Chemo toxicity: A common gene test could save hundreds of lives each year

by Arthur Allen, KFF Health NewsCredit: Unsplash/CC0 Public DomainOne January morning in 2021, Carol Rosen took a standard treatment for metastatic breast cancer. Three gruesome weeks later, she died

Updated on:March 30,2024 0

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on: March 30,2024 0

Drug-pricing program improves prostate cancer treatment adherence, finds study

by Nicole Fawcett,University of MichiganCredit: Unsplash/CC0 Public DomainProstate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to

Updated on:March 30,2024 0

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on: March 30,2024 0

Revealing characteristics of circulating cell-free RNA in the blood of liver cancer patients

byScience China PressMOF materials efficiently enrich circulating nucleic acids (cfDNA and cfRNA) in blood through a simple operational process, enabling various downstream nucleic acid detectio

Updated on:March 30,2024 0

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on: March 30,2024 0

'3D mammography' almost halves the incidence of breast cancer between two screening tests in clinical trial

byUniversity of CórdobaDBT interval carcinoma. A 60-year-old asymptomatic patient who underwent a repeat mammographic study 20months after the screening study interpreted as normal due to

Updated on:March 30,2024 0

Study discusses liquid biopsy as a game changer for early lung cancer detection

by Cactus CommunicationsCredit: CC0 Public DomainIn 2020, 1.8 million people succumbed to lung cancer. The late-stage discovery of lung cancer is one of the glaring challenges faced by the medical com

Updated on: March 30,2024 0

Study discusses liquid biopsy as a game changer for early lung cancer detection

by Cactus CommunicationsCredit: CC0 Public DomainIn 2020, 1.8 million people succumbed to lung cancer. The late-stage discovery of lung cancer is one of the glaring challenges faced by the medical com

Updated on:March 30,2024 0

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi

Updated on: March 30,2024 0

New research results explore the safety of short-term cultivated CAR T cells in cancer immunotherapy

by Susanne Stöcker, Paul-Ehrlich-Institut - Bundesinstitut für Impfstoffe und biomedizinische ArzneimittelTo make CAR T cells available to all patients, various strategies facilitating the manufacturi

Updated on:March 30,2024 0

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on: March 30,2024 0

Delayed treatment effect predicting (DTEP) model found to enhance precision in immuno-oncology trial designs

by Science China PressAt the trial design stage, by inputting information on treatment stage, cancer type, and experimental and control arm regimens, investigators can utilize the nomogram or web

Updated on:March 30,2024 0

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on: March 30,2024 0

Hypofractioned post-prostatectomy radiotherapy new acceptable practice standard based on NRG Oncology trial findings

by NRG OncologyResults from the Phase III NRG Oncology NRG-GU003 clinical trial comparing hypofractioned post-prostatectomy radiotherapy (HYPORT) to conventionally fractioned post-prostatectomy radiot

Updated on:March 30,2024 0

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024 0

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024 0

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t

Updated on: March 30,2024 0

AI-based app can help physicians find skin melanoma

by Karin Söderlund,Swedish Research CouncilGraph showing the relationships between the primary care physicians' (PCPs') reported degree of melanoma suspicion, final tumor diagnosis and t

Updated on:March 30,2024 0

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on: March 30,2024 0

Genetically engineered dendritic cells enhance the power of immunotherapy against lung cancer

by Denise Heady,University of California, Los AngelesGraphical Abstract. Credit:Cell Reports Medicine(2024). DOI: 10.1016/j.xcrm.2024.101479A study by researchers at the UCLA Health

Updated on:March 30,2024 0